- Report
- July 2024
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- June 2024
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- August 2024
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- May 2024
- 129 Pages
Global
From €5559EUR$5,950USD£4,702GBP
- Report
- April 2025
- 269 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 391 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 376 Pages
Global
From €5091EUR$5,450USD£4,307GBP
- Report
- April 2025
- 265 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 199 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 271 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 403 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 360 Pages
Global
From €5091EUR$5,450USD£4,307GBP
- Report
- April 2025
- 262 Pages
Global
From €5232EUR$5,600USD£4,426GBP
- Report
- April 2025
- 183 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- April 2025
- 196 Pages
Global
From €5091EUR$5,450USD£4,307GBP
- Report
- April 2025
- 182 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- April 2025
- 196 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- April 2025
- 192 Pages
Global
From €5091EUR$5,450USD£4,307GBP
- Report
- April 2025
- 196 Pages
Global
From €4624EUR$4,950USD£3,912GBP
- Report
- April 2025
- 181 Pages
Global
From €4624EUR$4,950USD£3,912GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more